09 Jun EFSA rejects 86-study strong Valio probiotic gut health claim
In what may be the most contentious rejection yet, EFSA’s health claims panel has refused Valio’s gut health dossier based on the Lactobacillus rhamnosus GG (LGG) strain (used in products such as Valio's Gefilus, the first clinically-backed probiotic consumer product on the
European...